Nonalcoholic Steatohepatitis (NASH) Overview
Learn About Nonalcoholic Steatohepatitis (NASH)
View Main Condition: Non-Alcoholic Fatty Liver Disease
Mgmc LLC
Arul Thomas is a Hepatologist in Annapolis, Maryland. Dr. Thomas has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His top areas of expertise are Hepatitis, Hepatitis C, Cirrhosis, Endoscopy, and Liver Transplant.
Chesapeake Digestive Associates, PC
Barry Cukor is a Gastroenterologist in Annapolis, Maryland. Dr. Cukor and is rated as an Experienced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Gas Bloat Syndrome, Trichohepatoenteric Syndrome, Gastrectomy, and Endoscopy.
Chesapeake Digestive Associates, PC
Charles King is a Gastroenterologist in Annapolis, Maryland. Dr. King and is rated as an Experienced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His top areas of expertise are Angiodysplasia of the Colon, Esophagitis, Gastroesophageal Reflux Disease (GERD), Colonoscopy, and Endoscopy.
Summary: This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The study will enroll subjects in two cohorts for a total samples size of 1650 subjects.
Summary: This is a multi-center, prospective, observational registry platform study aimed at describing the clinical characteristics and diagnosis and treatment patterns of Chinese patients with nonalcoholic steatohepatitis (NASH) with fibrosis.